Hypoglycemia on AIs

Last Modified: January 29, 2010

Share article


Dear OncoLink "Ask The Experts,"

I completed taxotere, carboplatin, and Herceptin chemotherapy in October. I started just Herceptin in October and Arimidex in November. I am an insulin-dependent diabetic; I wear an insulin pump. I have been experiencing severe hypoglycemic episodes requiring emergency room treatment since I started the Arimidex. I have spoken with my oncologist and my endocrinologist, and neither one has any helpful information, except, of course, to reduce my basal rates on my pump, which I had already done. Have you or your team had more experience with diabetics and chemo? Can you help me with any further guidance regarding my Arimidex?


Kevin R. Fox, MD, , responds:

Unfortunately, I have never encountered this problem. I would recommend empirically stopping the Arimidex and see if the episodes decrease, then consider an alternative form of hormonal treatment.

Studies outline new options for the standard treatment of various lymphoma types

Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.

I Wish You Knew

Understanding prostate cancer screening

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More